Acko Targets $250 Million Confidential IPO at $2‑2.5 Billion Valuation

Context: Acko, founded in 2017 by Varun Dua, sells general, health and life insurance directly to consumers without agents. In FY25 it reported revenue of ₹2,887 crore (≈$350 million) and a net loss of ₹424 crore (≈$51 million), narrowing the loss from ₹670 crore in FY24. Investors including General Atlantic, Multiples PE, Accel, Elevation and CPP Investments have committed more than $583 million to the company.

Key Facts: The confidential IPO seeks to raise roughly $250 million at a $2‑2.5 billion valuation. Morgan Stanley, Kotak Securities and ICICI Securities are appointed as book‑running lead managers, and the draft red herring prospectus is expected before the end of June. For benchmark, HDFC Life (NSE: HDFCLIFE) holds a market cap of about ₹1.4 lakh crore (~$17 billion) and was up 0.9% in the latest session; ICICI Prudential Life (NSE: ICICIPRULI) sits near ₹1.2 lakh crore (~$15 billion), down 0.2%; PolicyBazaar (NSE: POLICYBZR) is valued at roughly ₹60 thousand crore (~$7.2 billion), up 1.4%.

What It Means: Proceeds from the IPO could be used to expand product lines, invest in technology and reduce the operating loss. A confidential filing lets the company gauge investor interest before setting a final price band, a common tactic for volatile tech listings. Market watchers will assess whether Acko’s valuation aligns with growth expectations relative to established listed insurers.

Investors will watch the final prospectus filing, the pricing band set by the lead managers, and how Acko’s valuation stacks up against listed peers once trading begins.